Concepedia

Christopher Moxham

CM

Statistics

Publications

9

Citations

825

H-Index

9

Active since

1985

Affiliations

State University of New York(Current)

Stony Brook University

Burroughs Wellcome Fund

Christopher Moxham is an author at State University of New York specializing in medicine, drug discovery, and diabetes.

Top concepts

Publications per year

1985–2008

9

Publications

9

Insulin-like Growth Factor I Receptor β-Subunit Heterogeneity

Christopher Moxham, Vincent Duronio, Steven Jacobs · Journal of Biological Chemistry · 1989 · 260 citations · Full text

Novel Benzofuran and Benzothiophene Biphenyls as Inhibitors of Protein Tyrosine Phosphatase 1B with Antihyperglycemic Properties

Michael S. Malamas, Janet Sredy, Christopher Moxham et al. · Journal of Medicinal Chemistry · 2000 · 210 citations · Full text

, , +18

PTP1B Inhibition and Antihyperglycemic Activity in the ob/ob Mouse Model of Novel 11-Arylbenzo[<i>b</i>]naphtho[2,3-<i>d</i>]furans and 11-Arylbenzo[<i>b</i>]naphtho[2,3-<i>d</i>]thiophenes

Jay Wrobel, Janet Sredy, Christopher Moxham et al. · Journal of Medicinal Chemistry · 1999 · 126 citations · Full text

, , +21

Mammalian beta 1- and beta 2-adrenergic receptors. Immunological and structural comparisons.

Christopher Moxham, Shaji T. George, M P Graziano et al. · Journal of Biological Chemistry · 1986 · 56 citations · Full text

Safety Assessment, In Vitro and In Vivo, and Pharmacokinetics of Emivirine, a Potent and Selective Nonnucleoside Reverse Transcriptase Inhibitor of Human Immunodeficiency Virus Type 1

George M. Szczech, P A Furman, George R. Painter et al. · Antimicrobial Agents and Chemotherapy · 2000 · 47 citations · Full text

Rows per page

1–5 of 9